Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K051187
    Date Cleared
    2005-06-08

    (30 days)

    Product Code
    Regulation Number
    876.5860
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    REXEED SERIES DIALYZERS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    REXEED Series Dialyzers is intended for use for hemodialysis treatment of patients who have chronic or acute renal failure. REXEED Series Dialyzers must be used by a physician familiar with hemodialysis and under single or initial use conditions. REXEED Series Dialyzers have been evaluated under reprocessing and reuse conditions for all REXEED-UR/R Series Dialyzers. Based on the results from these evaluations, REXEED-UR/R Series Dialyzers may be reprocessed for reuse on the same patient. If reprocessing Series Dialyzers may be reprocessed for reuse on the same patient. If reprocessing is elected, it is recommended that the reuse be done under the conditions as existed in the in vitro and confirmatory clinical studies as conditions as "Existed" in "the "in "the "ht" "ht" "hat REXEED-UR/R Series Dialyzers recommisinced inimediately corrent reprocessed with agents and/or processes other than these, and the performance of the dialyzers under other conditions are not known and cannot be recommended. Accordingly:
    (1) The reprocessed dialyzer may be used only if the residual Total Cell Volume The reprocessed that 20% of the original TCV and if such dialyzer otherwise meets (TCV) is at least 60% of these instruction for use and the instruction of the the acceptance officilized. Furthermore, the policies, instructions, and criteria reprocessing system annized. Furthernore, mag dialyzer performance, residual of the ind/or dialyzer leakage or damage) should be followed.
    (2) The reprocessing agent may mixture of hydrogen peroxide and peroxyacetic The reprocessing agent may intinues of the Renatron® Dialyzer Reprocessing System (RS 8300), manufactured by Renal Systems, Inc.
    (3) The instructions provided by the manufacturer of the chosen reprocessing agent must be followed in reprocessing the dialyzer.
    (4) The reprocessed dialyzer may be used only on dialysis systems equipped with volumetric ultrafiltration controllers.

    Device Description

    The line of Asahi REXEED Series Dialyzers (hereinafter called REXEED) is a family of high permeability hollow fiber dialyzers intended for the treatment of patients with acute or chronic renal failure. REXEED-U/S are designed for single use and REXEED-UR/R are designed for reuse. The REXEED dialyers are constructed of reusable hollow fiber (polysulfone) membranes, housed within a plastic casing of styrene butadiene block copolymer and are gamma sterilized prior to shipment.

    Modifications made in this 510(k) including the followings. (1) The shape modification of polysulfone hollow fibers to the crimped was implemented. The REXEED dialyzers with crimped hollow fibers is added to the existing APS Series Dialyzers (hereafter called APS) cleared under K001250 and; (2) the REXEED dialyzers membrane surface area ranges from 1.5m² to 2.5m², while that of APS ranges from 0.8 m² to 2.1 m² and; (3) mixture of hydrogen peroxide and peroxyacetic acid (e.g., Renalin®) is used as reprocessing agent) and; (4) accordingly, change in the Instruction For Use (IFU) in regard to reprocessing agent.

    AI/ML Overview

    The provided text describes modifications to the Asahi REXEED Series Dialyzers and their substantial equivalence to predicate devices, but it does not contain a detailed study report with specific acceptance criteria and performance data in a table format, nor does it include information on sample sizes for test and training sets, expert qualifications, or MRMC studies.

    Based on the available information, here's what can be extracted and what is missing:

    1. Table of Acceptance Criteria and Reported Device Performance

    Not available in the provided text. The document states:

    "All test results meet the acceptance criteria, and proved that those modifications to be appropriate."
    and
    "All design verification tests based on the result of risk analysis and design input proved that the REXEED dialyzers are substantially equivalent in intended use, design, principle of operation, technology, materials, specifications, and performance to the existing APS cleared under K001250 and K041726, Fresenius Optiflux F200A cleared under K003498, and Gambro Polyflux 24S and Polyflux 24R cleared under K010667, with the exception of using mixture of hydrogen peroxide and peroxyacetic acid (e.g., Renalin®)."

    This indicates that acceptance criteria were met, but the specific criteria and quantitative performance results are not detailed.

    2. Sample Size Used for the Test Set and Data Provenance

    Not available in the provided text. The document mentions "Design verification tests," but does not specify the sample size or the nature of the data (e.g., in vitro, animal, human; country of origin; retrospective or prospective).

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    Not applicable. The document describes a device modification verification, not a study involving expert-established ground truth for a diagnostic AI device.

    4. Adjudication Method for the Test Set

    Not applicable, as there's no mention of a test set requiring adjudication in the context of expert consensus.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done

    No, an MRMC study was not done. This type of study is typically for evaluating diagnostic performance of an AI system with human readers, which is not the context of this device modification submission.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) Was Done

    Not applicable. This is a medical device (dialyzer) modification, not an algorithm.

    7. The Type of Ground Truth Used

    The "ground truth" in this context refers to the established performance and safety parameters of the predicate devices. The modifications were evaluated against "design verification tests based on the result of risk analysis and design input" to prove substantial equivalence to these predicate devices.

    8. The Sample Size for the Training Set

    Not applicable. This is not an AI/machine learning device.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable. This is not an AI/machine learning device.

    Summary of available and missing information:

    Information RequestedAvailability in TextDetails/Explanation
    1. Table of Acceptance Criteria and Reported Device PerformanceNot Available (details missing)States "All test results meet the acceptance criteria" and "proved that the REXEED dialyzers are substantially equivalent", but no specific table or data.
    2. Sample Size for Test Set & Data ProvenanceNot AvailableMentions "Design verification tests" but no sample size, origin, or type of data.
    3. Number & Qualifications of Experts for Ground Truth (Test Set)Not ApplicableNot an AI/diagnostic device study requiring expert ground truth.
    4. Adjudication Method (Test Set)Not ApplicableNot an AI/diagnostic device study.
    5. MRMC Comparative Effectiveness StudyNoNot relevant for this type of device modification.
    6. Standalone Algorithm Performance StudyNot ApplicableNot an algorithm.
    7. Type of Ground Truth UsedPredicate Device PerformanceEvaluation against established performance and safety of predicate devices and risk analysis.
    8. Sample Size for Training SetNot ApplicableNot an AI/machine learning device.
    9. How Ground Truth for Training Set Was EstablishedNot ApplicableNot an AI/machine learning device.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1